Blog

Celltex autologous stem cell case study published in Stem Cells and Development demonstrates favorable response in … – PR Newswire (press release)

Celltex autologous stem cell case study published in Stem Cells and Development demonstrates favorable response in …
PR Newswire (press release)
Celltex Chief Scientific Officer, Dr. Jane Young, MD, PhD, is part of the research team who authored the case study focused on two pediatric rheumatoid arthritis patients who are responding favorably to autologous mesenchymal stem cell therapy using
$145.8 Million Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source – Global Forecasts to 2021 …Business Wire (press release)


Stem cell therapy for the treatment of Peyronie's disease.UroToday
Stem Cell Therapy Market Report, Analysis and Trends 2017satPRnews (press release)
WhaTech
all 6 news articles »

2017-03-13 NEWS

Celltex autologous stem cell case study published in Stem Cells and Development demonstrates favorable response in … – PR Newswire (press release)

Celltex autologous stem cell case study published in Stem Cells and Development demonstrates favorable response in …
PR Newswire (press release)
Celltex Chief Scientific Officer, Dr. Jane Young, MD, PhD, is part of the research team who authored the case study focused on two pediatric rheumatoid arthritis patients who are responding favorably to autologous mesenchymal stem cell therapy using
$145.8 Million Stem Cell Therapy Market by Type, Therapeutic Application, Cell Source – Global Forecasts to 2021 …Business Wire (press release)


Stem cell therapy for the treatment of Peyronie's disease.UroToday
Stem Cell Therapy Market Report, Analysis and Trends 2017satPRnews (press release)
WhaTech
all 6 news articles »

2017-03-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.